Detalhe da pesquisa
1.
ESBL-positive Escherichia coli and Klebsiella pneumoniae isolates from across Canada: CANWARD surveillance study, 2007-18.
J Antimicrob Chemother
; 76(11): 2815-2824, 2021 10 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34378029
2.
Comparison of phenotypic antimicrobial susceptibility testing results and WGS-derived genotypic resistance profiles for a cohort of ESBL-producing Escherichia coli collected from Canadian hospitals: CANWARD 2007-18.
J Antimicrob Chemother
; 76(11): 2825-2832, 2021 10 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34378044
3.
In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coli.
Antimicrob Agents Chemother
; 63(1)2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30397056
4.
Dramatic rise in the proportion of ESBL-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates identified in Canadian hospital laboratories from 2007 to 2016.
J Antimicrob Chemother
; 74(Suppl 4): iv64-iv71, 2019 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31505647
5.
Antimicrobial-resistant pathogens in Canadian ICUs: results of the CANWARD 2007 to 2016 study.
J Antimicrob Chemother
; 74(3): 645-653, 2019 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30500898
6.
Trends in antimicrobial resistance over 10 years among key bacterial pathogens from Canadian hospitals: results of the CANWARD study 2007-16.
J Antimicrob Chemother
; 74(Suppl 4): iv22-iv31, 2019 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31505648
7.
42936 pathogens from Canadian hospitals: 10 years of results (2007-16) from the CANWARD surveillance study.
J Antimicrob Chemother
; 74(Suppl 4): iv5-iv21, 2019 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31505641
8.
In vitro activity of ceftazidime-avibactam against 338 molecularly characterized gentamicin-nonsusceptible Gram-negative clinical isolates obtained from patients in Canadian hospitals.
Antimicrob Agents Chemother
; 59(6): 3623-6, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25824208
9.
In Vitro activity of fosfomycin against Escherichia coli isolated from patients with urinary tract infections in Canada as part of the CANWARD surveillance study.
Antimicrob Agents Chemother
; 58(2): 1252-6, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24323476
10.
Trends in antibiotic resistance over time among pathogens from Canadian hospitals: results of the CANWARD study 2007-11.
J Antimicrob Chemother
; 68 Suppl 1: i23-9, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23587775
11.
Molecular epidemiology of extended-spectrum ß-lactamase-, AmpC ß-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
J Antimicrob Chemother
; 68 Suppl 1: i57-65, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23587779
12.
Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study.
J Antimicrob Chemother
; 68 Suppl 1: i7-22, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23587781